ID: ALA590527

Max Phase: Preclinical

Molecular Formula: C12H20N5O12P3S

Molecular Weight: 551.30

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)CP(=O)(O)O)[C@@H](O)[C@H]3O)c2n1

Standard InChI:  InChI=1S/C12H20N5O12P3S/c1-33-12-15-9(13)6-10(16-12)17(3-14-6)11-8(19)7(18)5(28-11)2-27-32(25,26)29-31(23,24)4-30(20,21)22/h3,5,7-8,11,18-19H,2,4H2,1H3,(H,23,24)(H,25,26)(H2,13,15,16)(H2,20,21,22)/t5-,7-,8-,11-/m1/s1

Standard InChI Key:  DSYSALVZZZNDFY-IOSLPCCCSA-N

Associated Targets(Human)

Serum 1292 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Ectonucleoside triphosphate diphosphohydrolase 1 116 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Ectonucleoside triphosphate diphosphohydrolase 2 116 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Ectonucleoside triphosphate diphosphohydrolase 3 108 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Ectonucleoside triphosphate diphosphohydrolase 8 96 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 635 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Ectonucleotide pyrophosphatase/phosphodiesterase family member 3 241 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Purinergic receptor P2Y2 1109 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Pyrimidinergic receptor P2Y4 598 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Purinergic receptor P2Y1 1327 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

P2Y purinoceptor 1 470 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Pyrimidinergic receptor P2Y6 121 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Rattus norvegicus 775804 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Oryctolagus cuniculus 11301 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 551.30Molecular Weight (Monoisotopic): 551.0042AlogP: -0.80#Rotatable Bonds: 9
Polar Surface Area: 269.90Molecular Species: ACIDHBA: 14HBD: 7
#RO5 Violations: 3HBA (Lipinski): 17HBD (Lipinski): 8#RO5 Violations (Lipinski): 3
CX Acidic pKa: 1.38CX Basic pKa: 5.16CX LogP: -5.24CX LogD: -9.39
Aromatic Rings: 2Heavy Atoms: 33QED Weighted: 0.11Np Likeness Score: 0.60

References

1. Eliahu SE, Camden J, Lecka J, Weisman GA, Sévigny J, Gélinas S, Fischer B..  (2009)  Identification of hydrolytically stable and selective P2Y(1) receptor agonists.,  44  (4): [PMID:18760862] [10.1016/j.ejmech.2008.07.015]
2. Eliahu S, Barr HM, Camden J, Weisman GA, Fischer B..  (2010)  A novel insulin secretagogue based on a dinucleoside polyphosphate scaffold.,  53  (6): [PMID:20175517] [10.1021/jm901621h]
3. Eliahu S, Martín-Gil A, Perez de Lara MJ, Pintor J, Camden J, Weisman GA, Lecka J, Sévigny J, Fischer B..  (2010)  2-MeS-beta,gamma-CCl2-ATP is a potent agent for reducing intraocular pressure.,  53  (8): [PMID:20337495] [10.1021/jm100030u]
4. Lecka J, Ben-David G, Simhaev L, Eliahu S, Oscar J, Luyindula P, Pelletier J, Fischer B, Senderowitz H, Sévigny J..  (2013)  Nonhydrolyzable ATP analogues as selective inhibitors of human NPP1: a combined computational/experimental study.,  56  (21): [PMID:24083941] [10.1021/jm400918s]

Source